TUESDAY, June 7, 2022 (HealthDay News) — Open-source automated insulin delivery (AID) systems are an effective and safe way for people with type 1 diabetes to control their blood sugar levels, researchers say. The AID systems combine an insulin pump, a continuous glucose monitor (CGM), and an algorithm that automaticallyContinue Reading
TUESDAY, June 7, 2022 (HealthDay News) — High-tech devices and communication helped ease the impact of COVID-19 lockdowns on children with type 1 diabetes, researchers said in a new study. Pandemic shutdowns caused significant disruptions in health care, and previous studies have shown that diabetes patients had worse blood sugarContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Obesity is a well-known risk factor for type 2 diabetes. Now, a large new study adds to evidence that it also contributes to the much less common type 1 diabetes. The study, of nearly 1.5 million Israeli teenagers, found that those who wereContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Patients with advanced cancer often suffer crippling fatigue, but there has been little in the way of relief for them as they battle their disease. Now, a new investigation may have landed on a surprising solution — a dummy pill that contains noContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A newly approved drug for type 2 diabetes may be a game-changer for treating obesity, too. Given as a shot once a week, tirzepatide works on two naturally occurring hormones that help tell the brain that you are full. It may be asContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — A small study delivers startling results on the power of a new immunotherapy treatment against rectal cancer: The drug triggered remission in all the patients who got it. All of them had mismatch repair-deficient (MMRd) locally advanced rectal cancer and were given dostarlimabContinue Reading
MONDAY, June 6, 2022 (American Heart Association News) — Brian Kennedy was living his dream. A piano prodigy, he moved from his hometown of Kansas City, Missouri, to Los Angeles in 2003, when he was 20. He started out as a musician for hire, playing a handful of instruments andContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Two “smart bomb” drugs are offering new hope to women with aggressive breast cancers, a pair of clinical trials show. Both medications are antibody-drug conjugates, consisting of a chemo drug that’s been wedded to an antibody that delivers the chemotherapy directly to cancerContinue Reading
MONDAY, June 6, 2022 (HealthDay News) — Diabetes increases the odds that a COVID-19 infection will be severe, and folks with diabetes may be up to four times more likely to develop long-lasting symptoms, new research suggests. “Though more data is needed, some early studies suggest that diabetes may beContinue Reading
New treatments may battle advanced breast cancers. Two “smart bomb” drugs are offering new hope to women with aggressive breast cancers, a pair of clinical trials show. Read more People with diabetes have 4 times the odds for long COVID. Symptoms may come and go or persist, and they canContinue Reading